Hamid Reza Matin

Kashan University of Medical Sciences

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Hamed Mirzaei

Kashan University of Medical Sciences

Zarrin Banikazemi

Kashan University of Medical Sciences

Saeed Sadr

Kashan University of Medical Sciences

Zatollah Asemi

Kashan University of Medical Sciences

Hasan Farajipour

Kashan University of Medical Sciences

Mohsen Taghizadeh

Kashan University of Medical Sciences

Mohsen Taghizadeh

Kashan University of Medical Sciences

Maryam Ebrahimi

Islamic Azad University Central Tehran Branch

Michael Aschner

Albert Einstein College of Medicine

Nasrin Sharifi

Kashan University of Medical Sciences

Cooperative Institutions

Kashan University of Medical Sciences

Shahid Beheshti University of Medical Sciences

Tehran University of Medical Sciences

Mashhad University of Medical Sciences

Iran University of Medical Sciences

High Institute for Education and Research in Transfusion Medicine

University of Guilan

Islamic Azad University Central Tehran Branch

Farabi Hospital

Shahrekord University of Medical Sciences

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

The effects of probiotics supplements on metabolic indices and clinical signs in patients with diabetic retinopathy, a randomized double blind clinical trial

Journal of Diabetes & Metabolic Disorders (2024)

Hasan Farajipour Hamid Reza Matin Zatollah Asemi Saeed Sadr Maryam Ebrahimi

Bifidobacterium bifidum

Placebo-controlled study

10.1007/s40200-024-01399-2

Cite

Citations (1)

Therapeutic effect of probiotics on metabolic indices and clinical signs in age-related macular degeneration

Journal of Immunoassay and Immunochemistry (2022)

Hasan Farajipour Saeed Sadr Hamid Reza Matin Michael Aschner Zatollah Asemi

Probiotics positively influence age-related macular degeneration (ARMD) given their propensity to attenuate oxidative and inflammatory stress. We addressed the impact of probiotics on metabolic profiles, clinical indices, inflammatory and oxidative stress parameters in ARMD patients. We performed a randomized, double-blind, placebo-controlled trial analyzing 57 subjects with ARMD aged between 50 and 85 years. Subjects were randomized into two groups, and received daily for 8 weeks either probiotic capsule or placebo. Fasting blood samples were obtained at baseline and after the 8-week intervention for the determination of metabolic profiles and oxidative stress biomarkers. After the 8-week intervention, compared with the placebo, probiotic supplementation significantly increased means HDL-cholesterol (Probiotic group: +3.86±4.42 vs. Placebo group: −0.55±4.93 mg/dL, P = .001), plasma total antioxidant capacity (TAC) (Probiotic group: +77.43±168.30 vs. Placebo group: −23.12±169.22 mmol/L, P = .02) and significantly decreased malondialdehyde (MDA) levels (Probiotic group: −0.18±0.46 vs. Placebo group: +0.18±0.25 µmol/L, P = .001). There was no significant effect of probiotic administration on other metabolic profiles and clinical symptoms. Overall, an eight-week probiotic administration among ARMD patients had beneficial effects on TAC, MDA and HDL-cholesterol levels; however, it did not affect clinical signs and other metabolic profiles.

Malondialdehyde

10.1080/15321819.2022.2159765

Cite

Citations (3)